Evidence map›Paper›PMID 38559299›Full record

ReviewACS central science2024

Natural Product Synthesis in the 21st Century: Beyond the Mountain Top.

Ryan A Shenvi

Open access · diamondAbstract readReview
In one paragraph

Review in ACS central science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Supernatural Products.The Chemist · 2025
    Article
  9. Review
  10. A View on Molecular Complexity from the GDB Chemical Space.Journal of chemical information and modeling · 2025
    Review
  11. Advancing Total Synthesis Through Skeletal Editing.Accounts of chemical research · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Gibberellic Acid (GAChemistry & biodiversity · 2025
    Review
  17. Review
  18. Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  19. Natural Product-Inspired Dopamine Receptor Ligands.Journal of medicinal chemistry · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Ryan A ShenviDepartment of Chemistry, Scripps Research, La Jolla, California 92037, United States.ORCID https://orcid.org/0000-0001-8353-6449
Scripps Research Institute · US

Funding

Unusual Pharmacophores and New Tools for Cross-CouplingR35GM122606 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI Ryan Ashok Shenvi · 2017 to 2026
$7.1M
Mapping brain-wide opioid actions by profiling neuronal activities and in vivo cellular target engagementR01DA059393 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI Laura M. Bohn, Ryan Ashok Shenvi · 2023 to 2026
$3.3M
Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignmentR01AT012075 · NCCIH · SCRIPPS RESEARCH INSTITUTE, THE · PI Laura M. Bohn, Ryan Ashok Shenvi · 2023 to 2026
$2.4M
Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignmentR56AT012075 · NCCIH · SCRIPPS RESEARCH INSTITUTE, THE · PI SHENVI, RYAN ASHOK · 2022 to 2022
$471k
NCCIH NIH HHS R01 AT012075NCCIH NIH HHS R56 AT012075NIDA NIH HHS R01 DA059393NIGMS NIH HHS R35 GM122606
6 · The paper itself

Abstract

Research into natural products emerged from humanity's curiosity about the nature of matter and its role in the

Identifiers

PMID38559299
PMCPMC10979479
OpenAlexW4391804686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.